Status:
TERMINATED
Coxib-inhibition of Duodenal Polyp Growth in FAP
Lead Sponsor:
Oslo University Hospital
Conditions:
Duodenal Polyposis
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
PHASE3
Brief Summary
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would s...
Eligibility Criteria
Inclusion
- FAP patient with previous colectomy and confirmed polyposis
Exclusion
- Pregnancy
- Malignancy
- NSAID hypersensitivity
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2004
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00844727
Start Date
September 1 2003
End Date
April 1 2004
Last Update
July 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Medicine, Rikshospitalet
Oslo, Oslo County, Norway, 0027